Botanical species · safety record
Piper betle
The EFSA Compendium of Botanicals holds 15 constituent measurements, 2 adverse-effect records and 2 genotoxicity assays for Piper betle. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Piper betle L.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 6 licensed products naming Piper betle as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- Eugenol2
- Phenylpropanoids2
- Cardiac glycosides1
- Isoquinoline alkaloids1
- Lignans1
- Myrcene1
- P-coumaric acid1
- Piperidine alkaloids1
- Piperine1
- Piperlonguminine1
Plant parts
- Leaves12
- Stem4
- stalk4
- Flower1
Preparations
- Solvent extraction14
- Essential oil3
Effect types
- Digestive2
Target tissues
- Digestive2
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Eugenol | Leaves | Essential oil | 6.4 Percent | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Isoquinoline alkaloids | Leaves | Solvent extraction | — | Chromatographic tests | Resolve DOI |
| Myrcene | Leaves | Essential oil | 1.1 Percent | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Phenylpropanoids | Flower | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Piperine | Stem / stalk | Solvent extraction | — | Chromatographic tests | Resolve DOI |
| Piperlonguminine | Stem / stalk | Solvent extraction | — | Chromatographic tests | Resolve DOI |
| Safrole | Leaves | Essential oil | 52.7 Percent | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Cardiac glycosides | Leaves | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Eugenol | Leaves | Solvent extraction | — | HPLC-DAD | No resolvable identifier |
| Lignans | Stem / stalk | Solvent extraction | — | Colorimetry, Spectroscopy (Spectrometry) and Photometry | No resolvable identifier |
| P-coumaric acid | Leaves | Solvent extraction | — | HPLC-DAD | No resolvable identifier |
| Phenylpropanoids | Leaves | Solvent extraction | — | HPLC-DAD | No resolvable identifier |
| Piperidine alkaloids | Stem / stalk | Solvent extraction | — | Colorimetry, Spectroscopy (Spectrometry) and Photometry | No resolvable identifier |
| Saponins | Leaves | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Tannins | Leaves | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Digestive | Digestive | Leaves | Solvent extraction | — | In vitro | No resolvable identifier |
| Digestive | Digestive | Leaves | Solvent extraction | — | In vitro | No resolvable identifier |
Genotoxicity testing
Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.
| Outcome | Endpoint | Test | Tested organism | Metabolic activation | Source |
|---|---|---|---|---|---|
| Positive | gene mutation | bacterial reverse mutation assay | Salmonella typhimurium (as organism) | Without | Resolve DOI |
| Positive | chromosome aberration | chromosome aberration assay | Hamster (as animal) | — | Resolve DOI |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Oliveira, Andreia P., Ferreira, Joana G., Riboira, Sofia., Andrade, Paula B., Valentao, Patricia. Bioactive Natural Products from Piper betle L. Leaves and their alpha-Glucosidase Inhibitory Potential . Records of natural products, 2016, vol. 10, no. 6, p. 771-781.
- Mohottalage, Susantha., Tabacchi, Raffaele., Guerin, Patrick M. Components from Sri Lankan Piper betle L. leaf oil and their analogues showing toxicity against the housefly, Musca domestica . Flavour and fragrance journal, 2007, vol. 22, no. 2, p. 130-138. DOI
- LeeChen, SF., Chen, CL., Ho, LY., Hsu, PC., Chang, JT., Sun, CM., Chi, CW., Liu, TY. Role of oxidative DNA damage in hydroxychavicol-induced genotoxicity. Mutagenesis, 1996, vol. 11, no. 5, p. 519-523. DOI
- De Vera, J.S., De Castro, M.E.G., Dulay, R.M.R. Phytochemical constituents and teratogenic effect of lyophilized extracts of Bixa orellana L. (Achuete) and Piper betle L. (Ikmo) leaves in Danio rerio Embryos. Der pharma chemica, 2016, vol. 8, no. 18, p. 432-437.
- Huang, Xiangzhong., Yin, Yan., Huang, Wenquan., Sun, Kuizong., Cheng, Chunmei., Bai, Lian., Dai, Yun. Alkaloids and lignans from stems of Piper betle .. Zhongguo zhong yao za zhi = zhongguo zhongyao zazhi = china journal of chinese materia medica, 2010, vol. 35, no. 17, p. 2285-8.
- Parmar, V.S., Jain, S.C., Gupta, S., Talwar, S., Rajwanshi, V.K., Kumar, R., Azim, A., Malhotra, S., Kumar, N., Jain, R., Sharma, N.K., Tyagi, O.D., Lawrie, S.J., Errington, W., Howarth, O.W., Olsen, C.E., Singh, S.K., Wengel, J. Polyphenols and alkaloids from piper species. Phytochemistry, 1998, vol. 49, no. 4, p. 1069-1078. DOI
- Srividya, Srinivasan., Pillai, Subramanian Iyyam., Subramaniana, Sorimuthu Pillai. Isolation and characterization of major phytochemicals from the leaves of Piper betle. Linn. International journal of pharmacy (hyderabad, india), 2015, vol. 5, no. 4, p. 1215-1233.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.